2025
Timing of repeat epinephrine to inform paediatric anaphylaxis observation periods: a retrospective cohort study
Dribin T, Sampson H, Zhang Y, Boyd S, Zhang N, Michelson K, Neuman M, Brousseau D, Mistry R, Freedman S, Aronson P, Bergmann K, Boswell B, Chinta S, Chua W, Cohen A, Cohen J, Daggett A, Davis J, Freeman J, Khanna K, Knoles C, Kwan K, Larsen C, Lee J, Lubell T, Metcalf A, Moake M, Nesiama J, Ngo T, Pulcini C, Russo C, Singh N, Srivastava G, Strutt J, Thapar V, Vander Wyst C, Walsh P, Wolnerman Y, Schnadower D, Academy of Pediatrics P, Kanngiesser A, McGarghan F, Dulchavsky A, Costalez J, DesPain A, Armanious M, Haghnazarian E, Brown-Whitehorn T, Weigert R, Dayan P, Meltzer J, Chowdhury N, Benedetti J, Sinziana C, Handorf A, Ruthford M, Devens M, Mecham C, Holland J, Casas T, Brown J, Panda P, Morrow A, Maready M, Nathani Y, Stevens M, Abraham G, Yen K, Cooper-Sood J, Woolf S. Timing of repeat epinephrine to inform paediatric anaphylaxis observation periods: a retrospective cohort study. The Lancet Child & Adolescent Health 2025, 9: 484-496. PMID: 40506197, DOI: 10.1016/s2352-4642(25)00139-7.Peer-Reviewed Original ResearchConceptsElectronic medical recordsEmergency departmentRetrospective cohort studyCohort studyMedical recordsDocumentation of symptomsCardiovascular involvementHealth-care facilitiesEpinephrine doseAcute allergic reactionsNational Institutes of HealthCumulative incidenceNational Center for Advancing Translational SciencesInstitutes of HealthChildren aged 6 monthsClinical ModificationHospital wardsIncidence rateICD-10Observation periodPrimary outcomeAllergic reactionsSecondary to medicationsInitiation to discontinuationKaplan-Meier analysisCarcinogenic Industrial Air Emissions and Lung Cancer Risk in a Cohort of 440,000 Americans.
Madrigal J, Fisher J, Pruitt C, Liao L, Graubard B, Ward M, Silverman D, Jones R. Carcinogenic Industrial Air Emissions and Lung Cancer Risk in a Cohort of 440,000 Americans. American Journal Of Respiratory And Critical Care Medicine 2025, 211: 1241-1252. PMID: 40315142, DOI: 10.1164/rccm.202409-1738oc.Peer-Reviewed Original ResearchConceptsLung cancer riskCancer riskAssociated with riskNIH-AARP DietEvaluate lung cancer riskLung carcinogensAssociated with lung cancerCox proportional hazards modelsNIH-AARPHealth StudyProportional hazards modelSquamous cell carcinomaStrong associationsAssociated with benzeneHazards modelIndustrial air emissionsEnrollment residenceCell carcinomaOverall riskLung cancer developmentSmokingAssociationRiskHistological subtypesLung cancerPediatric Nonfatal Firearm Injury Health Care Utilization.
Du J, Andrews A, Gastineau K, Lee L, Ranney M, Sacks C, Song Z, Fleegler E, Pulcini C. Pediatric Nonfatal Firearm Injury Health Care Utilization. 2025, 156 PMID: 40555422, DOI: 10.1542/peds.2024-070424.Peer-Reviewed Original ResearchConceptsFirearm injuriesHealth care outcomesHealth care useHealth care utilizationMental health diagnosesPediatric firearm injuriesHealth care spendingCare outcomesCare useInjury preventionCare utilizationPostinjury careInjured childrenHealth diagnosisCare spendingPrevention effortsHealth impactsIntervention effortsHealthLongitudinal researchChildrenPostinjuryCost-effectiveFirearmUnited StatesHealth Services Usage in Patients Receiving Buprenorphine for Opioid Use Disorder or Long-Term Opioid Therapy for Chronic Pain: Retrospective Cohort Study
Savitz S, Stevens M, Nath B, D'Onofrio G, Melnick E, Jeffery M. Health Services Usage in Patients Receiving Buprenorphine for Opioid Use Disorder or Long-Term Opioid Therapy for Chronic Pain: Retrospective Cohort Study. JMIR Formative Research 2025, 9: e66596. PMID: 40537088, DOI: 10.2196/66596.Peer-Reviewed Original ResearchConceptsIncidence rate ratiosLong-term opioid therapyIn-person careMental illness cohortOpioid use disorderIn-personTelemedicine visitsChronic painPain medicineOpioid therapyEmergency medicineMental healthFamily practiceHealth service usageChronic opioidsPercentage of visitsIn-person visitsIn-person treatmentPoor outcomeAdministrative claims dataUse disorderMedicare Advantage patientsOptumLabs Data WarehouseVulnerable patient populationCare deliveryLatent Health Status Trajectories in Individuals With New or Worsening Claudication Symptoms.
Grubman S, Romain G, Cleman J, Scierka L, Pajarillo C, Kluger J, Mena-Hurtado C, Smolderen K. Latent Health Status Trajectories in Individuals With New or Worsening Claudication Symptoms. Journal Of The American Heart Association 2025, 14: e039455. PMID: 40530482, DOI: 10.1161/jaha.124.039455.Peer-Reviewed Original ResearchConceptsHealth status trajectoriesPeripheral artery disease careStatus trajectoriesDisease careHealth statusClaudication symptomsTrajectory subgroupsPeripheral Artery QuestionnaireVascular specialty clinicsPeripheral artery questionnaire scoresHierarchical multivariable logistic regressionImprove health statusMultivariate logistic regressionClinically meaningful thresholdsRegistry of patientsPsychosocial factorsBiopsychosocial modelDepressive symptomsSpecialty clinicsAlcohol use disorderQuestionnaire scoresRecovery trajectoriesLogistic regressionHealthLatent trajectory modelsCriminal Justice-Involved Veterans Not Engaged in Primary Care in the Veterans Health Administration.
Tsai J, Lampros A, Clark S, Dunn A, O'Toole T. Criminal Justice-Involved Veterans Not Engaged in Primary Care in the Veterans Health Administration. Journal Of Primary Care & Community Health 2025, 16: 21501319251348134. PMID: 40525421, PMCID: PMC12174793, DOI: 10.1177/21501319251348134.Peer-Reviewed Original ResearchConceptsVeterans Health AdministrationPrimary care visitsPrimary careJustice-involved veteransCare visitsHealth AdministrationVeterans Health Administration medical recordsMental health/substance use treatmentVeterans Health Administration facilitiesIntegrated care initiativesVA primary careOutpatient medical careMilitary sexual traumaCare initiativesService useAssociated with useCriminal justice systemHealthcare needsService utilizationNon-HispanicRetrospective cohort studySubstance use disordersBehavioral healthcareMental healthSociodemographic characteristicsProposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences.
Huey R, Pritchett J, Vokinger K, Swenson W, Haddad T, Adelson K. Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences. American Society Of Clinical Oncology Educational Book 2025, 45: e473822. PMID: 40526882, DOI: 10.1200/edbk-25-473822.Peer-Reviewed Original ResearchConceptsCancer care deliveryCancer care costsSite of careRemote patient monitoringCare deliveryCancer careCost-containment strategiesUnited StatesTelehealth servicesCare costsVulnerable populationsPayment barriersPayment parityFacility feesCareStandard of careIncremental costHospitalHealthReimbursementPolicy changesPatient monitoringCancer treatmentUnintended consequencesComparator countriesPediatric Fellows and Their Ability to Meet Minimum Supervision Levels at Graduation.
Weiss P, Schwartz A, Boyer D, Chess P, Fussell J, McGann K, Moffatt M, Herman B, Turner D, Pitts S, Langhan M, High P, James S, Karnik R, Aye T, Stafford D, Rama J, Robinson B, Hsu D, Sauer C, Mehta J, Atlas M, Curran M, Mahan J, McFadden V, Kamin D, Kesselheim J, Czaja A, Dammann C, George R, Lopez M, Torres O, Mink R. Pediatric Fellows and Their Ability to Meet Minimum Supervision Levels at Graduation. 2025, 156 PMID: 40518135, DOI: 10.1542/peds.2025-070682.Peer-Reviewed Original ResearchMeSH KeywordsCertificationClinical CompetenceEducation, Medical, GraduateFellowships and ScholarshipsHumansPediatricsUnited StatesConceptsEntrustable professional activitiesPediatric fellowsSupervision levelPediatric subspecialty fellowsAmerican Board of PediatricsCertificate dataClinical competency committeeSubspecialty board certificationPatient careCertification ratesSubspecialty fellowsBoard certificationProgram directorsCompetency committeeAmerican BoardSubspecialty certification examinationsCertification examinationSubspecialtyGraduating fellowsPediatricFellowGraduatesSupervisionReadinessCareDelineating Life‐Course Percentile Curves and Normative Values of Multi‐Systemic Ageing Metrics in the United Kingdom, the United States, and China
Zhang L, Yu J, Jia X, Su Z, Hu Y, Zhang J, Yang W, Chen X, Hoogendijk E, Huang H, Liu Z. Delineating Life‐Course Percentile Curves and Normative Values of Multi‐Systemic Ageing Metrics in the United Kingdom, the United States, and China. Journal Of Cachexia Sarcopenia And Muscle 2025, 16: e13862. PMID: 40511588, PMCID: PMC12163542, DOI: 10.1002/jcsm.13862.Peer-Reviewed Original ResearchSocial Determinants of Health and Healthcare Utilization in Infants With Bronchopulmonary Dysplasia
Urbach H, Ostfeld‐Johns S, McCollum S, Weiss P, Kandil S, Brumer E. Social Determinants of Health and Healthcare Utilization in Infants With Bronchopulmonary Dysplasia. Pediatric Pulmonology 2025, 60: e71153. PMID: 40504047, DOI: 10.1002/ppul.71153.Peer-Reviewed Original ResearchConceptsSocial determinants of healthChildhood Opportunity IndexArea Deprivation IndexHealthcare utilizationED visitsImpact of social determinants of healthSocial determinants of health variablesInfluence of social determinants of healthEmergency departmentAssociated with fewer ED visitsAssociated with increased ED visitsHigh-deprivation neighborhoodsDeterminants of healthBronchopulmonary dysplasiaAdverse health outcomesMediation analysisDeprivation indexHealthcare useSocial determinantsNo significant associationHealth outcomesFollow-upHospital utilizationNeighborhood disadvantageRacial/ethnic differencesMulti-center randomized superiority clinical trial in the early phase of mechanically ventilated patients to preserve diaphragm thickness using non-invasive magnetic phrenic nerve stimulation: STIMIT ACTIVATOR 1 pivotal trial
Schreiber A, Subirà C, Sklar M, Santos M, Ko M, Panelli A, Schaller S, Theodore D, Rowley D, Watson D, Bonde P, Baedorf Kassis E, Talmor D, Ranieri M, Goligher E, Slutsky A, Brochard L. Multi-center randomized superiority clinical trial in the early phase of mechanically ventilated patients to preserve diaphragm thickness using non-invasive magnetic phrenic nerve stimulation: STIMIT ACTIVATOR 1 pivotal trial. Trials 2025, 26: 202. PMID: 40500715, PMCID: PMC12153206, DOI: 10.1186/s13063-025-08838-2.Peer-Reviewed Original ResearchConceptsVentilator-induced diaphragmatic dysfunctionPhrenic nerve stimulationMechanically ventilated patientsIntensive care unitNerve stimulationMechanical ventilationClinical trialsProcedure-related adverse eventsMagnetic phrenic nerve stimulationProlonged ventilatory dependencySevere chronic pulmonary diseaseRandomized multi-center studyDiaphragm thicknessMuscle thicknessMaximal inspiratory pressureMulti-center randomized clinical trialChronic pulmonary diseaseRandomized clinical trialsMeasure diaphragm thicknessMulti-center studyRandomized superiority clinical trialInvasive electrical stimulationVentilatory dependenceDiaphragmatic dysfunctionSuperiority clinical trialInpatient Outcomes for Patients With Peripheral Artery Disease Hospitalized for Acute Myocardial Infarction.
Gusdorf J, Faridi K, Wang T, Mena-Hurtado C, Smolderen K, Rymer J, Curtis J, Li S, Secemsky E. Inpatient Outcomes for Patients With Peripheral Artery Disease Hospitalized for Acute Myocardial Infarction. Journal Of The American Heart Association 2025, 14: e040526. PMID: 40497502, DOI: 10.1161/jaha.124.040526.Peer-Reviewed Original ResearchConceptsAcute myocardial infarction typesPeripheral arterial diseaseAcute myocardial infarctionIn-hospital mortalityPeripheral artery disease hospitalizationsIn-hospital outcomesAcute myocardial infarction hospitalizationsCardiac arrestHigh-risk populationAssociated with increased ratesLong-term riskRevascularized patientsInpatient outcomesMultivariable adjustmentHeart failureArtery diseasePrimary outcomeAdverse cardiovascular outcomesUS sitesHeightened riskAge groupsSecondary end pointsSubgroup analysisDialysis initiationCoronary artery diseaseHuman Health Impacts of Energy Transitions across the United States among Sociodemographic Subpopulations for the Year 2050
Stewart R, Kim H, Choi H, Song Y, Zhang Y, Gillingham K, Esty D, Hobbs B, Bell M. Human Health Impacts of Energy Transitions across the United States among Sociodemographic Subpopulations for the Year 2050. Environmental Science And Technology 2025, 59: 11995-12007. PMID: 40498102, DOI: 10.1021/acs.est.4c14326.Peer-Reviewed Original ResearchMeSH KeywordsAir PollutantsAir PollutionEnergy-Generating ResourcesFossil FuelsHumansParticulate MatterPublic HealthUnited StatesConceptsHuman health impactsConcentration-response functionsAmbient fine particlesImprove air qualityMonetized health benefitsGreenhouse gas emissionsEnvironmental health inequalitiesBaseline incidence ratePollution levelsAir qualityContiguous United StatesFine particlesHealth impactsGas emissionsMitigation strategiesSensitive to assumptionsFossil fuel productionPopulation projectionsFuel productionEconomic benefitsCobenefitsEnergy scenariosPollutionHealth benefitsEnergy transition policiesAcute Ischemic Stroke Risk Following Cardiac Interventions in the United States From 2016 to 2021
Koo A, Zhou L, Hameed I, Rivier C, Clocchiatti-Tuozzo S, Kamel H, Falcone G, Ney J, Sharma R, Matouk C, Yaghi S, Sheth K, de Havenon A. Acute Ischemic Stroke Risk Following Cardiac Interventions in the United States From 2016 to 2021. Neurology 2025, 105: e213766. PMID: 40493873, PMCID: PMC12165311, DOI: 10.1212/wnl.0000000000213766.Peer-Reviewed Original ResearchConceptsIntervention hospitalsSurvey weightsNon-Hispanic black ethnicityNIH Stroke ScaleStroke riskIschemic strokeFactors associated with ischemic strokeAssociated with female sexCardiac interventionsIschemic stroke riskIncidence of ischemic strokeVariables associated with riskRate of ischemic strokeNational Inpatient SampleHigh-risk populationDiagnosis-related groupsIntervention patientsCross-sectional cohortUnited StatesAcute ischemic stroke riskIn-hospital deathRisk of strokeSecondary analysisBlack ethnicityInpatient mortalityStill we rise: research on bias and discrimination will endure
Gonsalves G. Still we rise: research on bias and discrimination will endure. International Journal For Equity In Health 2025, 24: 167. PMID: 40495157, PMCID: PMC12153171, DOI: 10.1186/s12939-025-02537-9.Peer-Reviewed Original ResearchConceptsMeasures of implicitCommunity health centersVaping behaviorUS National Institutes of HealthNational Institutes of HealthExplicit measuresMeta-regression approachCurrent smokingHealth centersInstitutes of HealthAssess smokingCurrent US administrationConduct of researchUS National InstitutesDonald J. TrumpPresident Donald J. TrumpLogistic regressionResearch fundersCenter membersUS administrationDominant groupPolitical interferenceTrump administrationIdeological reasonsComparing targetsCannabis Legalization and Opioid Use Disorder in Veterans Health Administration Patients
Mannes Z, Wall M, Alschuler D, Malte C, Olfson M, Livne O, Fink D, Keyhani S, Keyes K, Martins S, Cerdá M, Sacco D, Gutkind S, Maynard C, Sherman S, Saxon A, Hasin D. Cannabis Legalization and Opioid Use Disorder in Veterans Health Administration Patients. JAMA Health Forum 2025, 6: e251369. PMID: 40512510, PMCID: PMC12166489, DOI: 10.1001/jamahealthforum.2025.1369.Peer-Reviewed Original ResearchConceptsVeterans Health AdministrationVeterans Health Administration patientsMedical cannabis lawsOpioid use disorderPrevalence of opioid use disorderClassification of DiseasesRecreational cannabis lawsChronic painVeterans Health Administration electronic health recordClinical ModificationConsistent with overall findingsState medical cannabis lawsInternational Statistical Classification of DiseasesReceipt of prescription opioidsStatistical Classification of DiseasesElectronic health recordsInternational Classification of DiseasesNon-Hispanic whitesOpioid use disorder diagnosisOpioid use disorder prevalenceInternational Statistical ClassificationDifference-in-differences analysisCannabis lawsUse disorderBurden of opioid use disorderPublic Health Implications of Legal Challenges to the FDA’s Regulation of Laboratory-Developed Tests
Kadakia K, Ross J, Ramachandran R. Public Health Implications of Legal Challenges to the FDA’s Regulation of Laboratory-Developed Tests. JAMA Health Forum 2025, 6: e252233. PMID: 40540283, DOI: 10.1001/jamahealthforum.2025.2233.Peer-Reviewed Original ResearchMeSH KeywordsGovernment RegulationHumansPublic HealthUnited StatesUnited States Food and Drug AdministrationConceptsLaboratory-developed testsFood and Drug AdministrationPublic health implicationsEastern District of TexasSupreme Court's recent decisionAssociation of Molecular PathologyCourt's recent decisionUS District CourtClinical evidence of safetyRegulate laboratory-developed testsFood and Drug Administration regulationsUS Food and Drug AdministrationPublic health concernPublic health emergencyMedical Devices AuthorityChevron doctrineDistrict CourtAgency interpretationsClinical careHealth technologiesImplementing statutesComplex molecular testsLegal challengesAmendment ActRegulatory remitTitration and discontinuation of semaglutide for weight management in commercially insured US adults
Xu Y, Carrero J, Chang A, Inker L, Zhang D, Mukhopadhyay A, Blecker S, Horwitz L, Grams M, Shin J. Titration and discontinuation of semaglutide for weight management in commercially insured US adults. Obesity 2025, 33: 1243-1248. PMID: 40464214, DOI: 10.1002/oby.24315.Peer-Reviewed Original ResearchConceptsDose escalation scheduleHigher discontinuation rateDiscontinuation ratesWeight managementMultivariate Cox regressionUS adultsAssociated with discontinuationCommercially insured adultsEarly discontinuationAssociated with low household incomeCox regressionSemaglutideLowest quintileHighest quintileDelivery of evidence-based careLower household incomeMonthsEvidence-based careCopayment amountQuintileAdultsReduce financial barriersDiscontinuationEducation levelIdentified factorsGender Differences in Medicare Practice and Payment of Neuroradiologists.
Malhotra A, Lee C, Khunte M, Futela D, Moily R, Payabvash S, Gandhi D, Wintermark M. Gender Differences in Medicare Practice and Payment of Neuroradiologists. American Journal Of Neuroradiology 2025, 46: 1093-1099. PMID: 40461255, PMCID: PMC12152790, DOI: 10.3174/ajnr.a8633.Peer-Reviewed Original ResearchPublic Water Arsenic and Birth Outcomes in the Environmental Influences on Child Health Outcomes Cohort
Nigra A, Bloomquist T, Rajeev T, Burjak M, Casey J, Goin D, Herbstman J, Ornelas Van Horne Y, Wylie B, Cerna-Turoff I, Braun J, McArthur K, Karagas M, Ames J, Sherris A, Bulka C, Padula A, Howe C, Fry R, Eaves L, Breton C, Cassidy-Bushrow A, Lewis J, MacKenzie D, Beene D, Farzan S, Sathyanarayana S, Hipwell A, Morello-Frosch R, Snyder B, Hartert T, Elliott A, O’Connor T, Kress A, Smith P, Newby L, Adair L, Jacobson L, Catellier D, McGrath M, Douglas C, Duggal P, Knapp E, Kress A, Blackwell C, Mansolf M, Lai J, Ho E, Cella D, Gershon R, Macy M, Das S, Freedman J, Mallal S, McLean J, Shah R, Shilts M, Alshawabkeh A, Cordero J, Meeker J, Trasande L, Camargo C, Hasegawa K, Zhu Z, Sullivan A, Dabelea D, Perng W, Bekelman T, Wilkening G, Magzamen S, Moore B, Starling A, Rinehart D, Koinis Mitchell D, D'Sa V, Deoni S, Mueller H, Duarte C, Monk C, Canino G, Posner J, Murray T, Lugo-Candelas C, Dunlop A, Brennan P, Hockett C, Elliott A, Ferrara A, Croen L, Hedderson M, Ainsworth J, Bacharier L, Bendixsen C, Gern J, Gold D, Hartert T, Jackson D, Johnson C, Joseph C, Kattan M, Khurana Hershey G, Lemanske, Jr. R, Lynch S, Miller R, O’Connor G, Ober C, Ownby D, Rivera-Spoljaric K, Ryan P, Seroogy C, Singh A, Wood R, Zoratti E, Habre R, Farzan S, Gilliland F, Hertz-Picciotto I, Bennett D, Schweitzer J, Schmidt R, LaSalle J, Hipwell A, Karr C, Bush N, LeWinn K, Sathyanarayana S, Zhao Q, Tylavsky F, Carroll K, Loftus C, Leve L, Ganiban J, Neiderhiser J, Weiss S, Litonjua A, McEvoy C, Spindel E, Tepper R, Newschaffer C, Lyall K, Volk H, Landa R, Ozonoff S, Piven J, Hazlett H, Pandey J, Schultz R, Dager S, Botteron K, Messinger D, Stone W, Ames J, O'Connor T, Miller R, Oken E, Hacker M, James-Todd T, O'Shea T, Fry R, Frazier J, Singh R, Rollins C, Montgomery A, Vaidya R, Joseph R, Washburn L, Gogcu S, Bear K, Rollins J, Hooper S, Taylor G, Jackson W, Thompson A, Daniels J, Hernandez M, Lu K, Msall M, Lenski M, Obeid R, Pastyrnak S, Jensen E, Sakai C, Santos H, Kerver J, Paneth N, Barone C, Elliott M, Ruden D, Fussman C, Herbstman J, Margolis A, Schantz S, Geiger S, Aguiar A, Tabb K, Strakovsky R, Woodruff T, Morello-Frosch R, Padula A, Stanford J, Porucznik C, Giardino A, Wright R, Wright R, Collett B, Baumann-Blackmore N, Gangnon R, McKennan C, Wilson J, Altman M, Aschner J, Stroustrup A, Merhar S, Moore P, Pryhuber G, Hudak M, Reynolds Lyndaker A, Lampland A, Rochelson B, Jan S, Blitz M, Katzow M, Brown Z, Chiuzan C, Rafael T, Lewis D, Meirowitz N, Poindexter B, Gebretsadik T, Osmundson S, Straughen J, Eapen A, Cassidy-Bushrow A, Wegienka G, Sitarik A, Woodcroft K, Urquhart A, Levin A, Johnson-Hooper T, Davidson B, Ma T, Barrett E, Blaser M, Dominguez-Bello M, Horton D, Jimenez M, Rosen T, Palomares K, Avalos L, Zhu Y, Hunt K, Newman R, Bloom M, Alkis M, Roberts J, Mumford S, Burris H, DeMauro S, Yee L, Hamvas A, Olidipo A, Haddad A, Eiland L, Spillane N, Suri K, Fisher S, Goldstein J, Mithal L, DeRegnier R, Maitre N, Nguyen R, JaKa M, Sidebottom A, Paidas M, Potter J, Ruby N, Duthely L, Jayakumar A, Young K, Maldonado I, Miller M, Slaughter J, Keim S, Lynch C, Venkatesh K, Whitworth K, Symanski E, Northrup T, Mendez-Figueroa H, Mosquera R, Karagas M, Madan J, MacKenzie D, Lewis J, Rennie B, Leventhal B, Kim Y, Bishop S, Nozadi S, Luo L, Lester B, Marsit C, Everson T, Loncar C, McGowan E, Sheinkopf S, Carter B, Check J, Helderman J, Neal C, Smith L. Public Water Arsenic and Birth Outcomes in the Environmental Influences on Child Health Outcomes Cohort. JAMA Network Open 2025, 8: e2514084. PMID: 40522663, PMCID: PMC12171937, DOI: 10.1001/jamanetworkopen.2025.14084.Peer-Reviewed Original ResearchConceptsBirth weight-for-gestational age z-scoreLow birth weightAge z-scoreAdjusted risk ratiosAdverse birth outcomesBirth outcomesBirth weightMaximum contaminant levelWater arsenicWater arsenic exposureRisk ratioGestational agePreterm birthZ-scoreContamination levelsCohort studyAssociated with adverse birth outcomesHigher risk of low birth weightArsenic exposureParent-infant dyadsRisk of low birth weightUS Environmental Protection Agency maximum contaminant levelChild health outcomesAssociated with birth outcomesEnvironmental Protection Agency maximum contaminant level
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply